Diagnosis of Alzheimer's disease using laser-induced breakdown spectroscopy and machine learning.
Journal:
Spectrochimica acta. Part B, Atomic spectroscopy
Published Date:
Jul 15, 2020
Abstract
Alzheimer's disease (AD) is a progressive incurable neurodegenerative disease and a major health problem in aging population. We show that the combined use of Laser-Induced Breakdown Spectroscopy (LIBS) and machine learning applied for the analysis of micro-drops of plasma samples of AD and healthy controls (HC) yields robust classification. Following the acquisition of LIBS spectra of 67 plasma samples from a cohort of 31 AD patients and 36 healthy controls (HC), we successfully diagnose late-onset AD (> 65 years old), with a total classification accuracy of 80%, a specificity of 75% and a sensitivity of 85%.
Authors
Keywords
No keywords available for this article.